Lydia King, PhD, MPH, is the Director of Biostatistics at Ce3 Inc. In this role, she provides strategic direction for biostatistics across multiple study teams, ensuring appropriate statistical techniques for all endpoints. Dr. King offers more than 20 years of experience in SAS programming, study design, and statistical analysis, with an emphasis in oncology trials in most recent years. Prior to her work in clinical trials, Dr. King spent a decade in academia where her research and analytical skills were displayed at professional conferences as well as in peer-reviewed publications. Dr. King holds a Bachelor of Science from the University of Alabama, a Master of Public Health from Emory University, and a PhD in Epidemiology from the Medical University of South Carolina.